Silo Pharma Inc
(SILO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 18 | 18 | 18 | 18 | 18 |
| Cost of Goods | 21 | 2 | 2 | 2 | 2 |
| Gross Profit | -3 | 17 | 17 | 17 | 17 |
| Operating Expenses | 1,170 | 1,267 | 1,112 | 1,831 | 1,028 |
| Operating Income | -1,152 | -1,249 | -1,094 | -1,813 | -1,010 |
| Interest Expense | 1 | 2 | 2 | 0 | 1 |
| Other Income | 42 | 46 | 65 | 83 | 82 |
| Pre-tax Income | -1,110 | -1,204 | -1,031 | -1,731 | -929 |
| Net Income Continuous | -1,110 | -1,204 | -1,031 | -1,731 | -929 |
| Net Income | $-1,110 | $-1,204 | $-1,031 | $-1,731 | $-929 |
| EPS Basic Total Ops | -0.12 | -0.19 | -0.23 | -0.38 | -0.22 |
| EPS Basic Continuous Ops | -0.12 | -0.19 | -0.23 | -0.39 | -0.22 |
| EPS Diluted Total Ops | -0.12 | -0.19 | -0.23 | -0.38 | -0.22 |
| EPS Diluted Continuous Ops | -0.12 | -0.19 | -0.23 | -0.39 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.12 | -0.19 | -0.23 | -0.41 | -0.22 |
| EBITDA(a) | $-1,149 | $-1,246 | $-1,091 | $-1,810 | $-1,010 |